SAN MATEO, Calif., Oct. 31 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing novel pain management therapies, announced today that it is scheduled to present on Monday, November 5, 2007 at the CIBC World Markets 18th Annual Healthcare Conference and on Tuesday, November 6, 2007 at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. Anthony DiTonno, President and Chief Executive Officer, will be presenting and Stephen Ghiglieri, Chief Financial Officer, will be available to respond to questions during the break out sessions.
Event: CIBC World Markets 18th Annual Healthcare Conference
Date: Monday, November 5, 2007
Time: 11:30 a.m. ET
Place: The Waldorf-Astoria Hotel, New York
Event: Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Date: Tuesday, November 6, 2007
Time: 10:55 a.m. ET
Place: New York Palace Hotel, New York
An audio Web cast of the Company's presentations will be available by going to the investor relations section of NeurogesX' Web site at http://www.neurogesx.com. A replay of the presentation will be available for 15 days.
About NeurogesX, Inc.
NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on
developing novel pain management therapies. Its initial focus is on chronic
peripheral neuropathic pain, includin
|SOURCE NeurogesX, Inc.|
Copyright©2007 PR Newswire.
All rights reserved